NCT04241562View on ClinicalTrials.gov

Validation of a Novel Cortical Biomarker Signature for Pain

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
TMD
Interventions
OTHER

Injection of Nerve Growth Factor

Injection of Nerve Growth Factor to the right masseter

Trial Locations (2)

2031

Neuroscience Research Australia, Sydney

21201

University of Maryland School of Dentistry, Baltimore

Sponsors
All Listed Sponsors
collaborator

Neuroscience Research Australia

OTHER

lead

University of Maryland, Baltimore

OTHER